- Home
- NXL vs ZDAI Comparison
NXL vs ZDAI Comparison
Compare NXL & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- ZDAI
- Stock Information
- Founded
- NXL 2010
- ZDAI 2022
- Country
- NXL United States
- ZDAI Hong Kong
- Employees
- NXL N/A
- ZDAI N/A
- Industry
- NXL Medical Specialities
- ZDAI General Bldg Contractors - Nonresidential Bldgs
- Sector
- NXL Health Care
- ZDAI Consumer Discretionary
- Exchange
- NXL Nasdaq
- ZDAI Nasdaq
- Market Cap
- NXL 17.8M
- ZDAI 14.8M
- IPO Year
- NXL 2022
- ZDAI 2024
- Fundamental
- Price
- NXL $1.52
- ZDAI $0.50
- Analyst Decision
- NXL Strong Buy
- ZDAI
- Analyst Count
- NXL 1
- ZDAI 0
- Target Price
- NXL $5.00
- ZDAI N/A
- AVG Volume (30 Days)
- NXL 10.4M
- ZDAI 178.4K
- Earning Date
- NXL 11-07-2025
- ZDAI 10-28-2025
- Dividend Yield
- NXL N/A
- ZDAI N/A
- EPS Growth
- NXL N/A
- ZDAI N/A
- EPS
- NXL N/A
- ZDAI N/A
- Revenue
- NXL $174,813.00
- ZDAI $19,275,673.00
- Revenue This Year
- NXL $38.28
- ZDAI N/A
- Revenue Next Year
- NXL $185.71
- ZDAI N/A
- P/E Ratio
- NXL N/A
- ZDAI N/A
- Revenue Growth
- NXL 16.42
- ZDAI 43.16
- 52 Week Low
- NXL $0.70
- ZDAI $0.37
- 52 Week High
- NXL $4.49
- ZDAI $107.36
- Technical
- Relative Strength Index (RSI)
- NXL 61.70
- ZDAI 34.20
- Support Level
- NXL $1.20
- ZDAI $0.53
- Resistance Level
- NXL $1.46
- ZDAI $0.60
- Average True Range (ATR)
- NXL 0.17
- ZDAI 0.05
- MACD
- NXL 0.04
- ZDAI -0.02
- Stochastic Oscillator
- NXL 57.89
- ZDAI 1.01
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.